ATP1b3 ELISA kit
- Known as:
- ATP1b3 Enzyme-linked immunosorbent assay test reagent
- Catalog number:
- DL-ATP1b3-Ra
- Product Quantity:
- 96T
- Category:
- Elisa Kits
- Supplier:
- WDSTD
- Gene target:
- ATP1b3 ELISA kit
Ask about this productRelated genes to: ATP1b3 ELISA kit
- Gene:
- ATP1B3 NIH gene
- Name:
- ATPase Na+/K+ transporting subunit beta 3
- Previous symbol:
- -
- Synonyms:
- FLJ29027, CD298
- Chromosome:
- 3q23
- Locus Type:
- gene with protein product
- Date approved:
- 1997-06-18
- Date modifiied:
- 2016-02-10
Related products to: ATP1b3 ELISA kit
Human ELC ELISA KIT 96 TEST
OxiSelect In Vitro ROS/RNS Assay Kit (Green Fluorescence), Trial Size
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect TBARS Assay Kit (MDA Quantitation), Trial Size
OxiSelect Total Antioxidant Capacity (TAC) Assay Kit, Trial Size
OxiSelectâ„¢ In Vitro ROS RNS Assay Kit (Green Fluorescence), Trial Size(1-3)-beta-D-glucan Sandwich ELISA, Double Antibody(1-Kit )11,12-EET DHET Immunoassay Kit(1-Kit )11,12-EET_DHET Immunoassay Kit(1-Kit) 11,12-DHET Immunoassay Kit(1-Kit) 14,15-DHET Human Urine ELISA Kit(1-Kit) 14,15-DHET Hypertension ELISA Kit(1-Kit) 14,15-DHET sEH activity ELISA Kit(1-Kit) 14,15-EET DHET Hypertension ELISA Kit Related articles to: ATP1b3 ELISA kit
- Increasing evidence suggests that disulfidptosis plays a crucial role in tumorigenesis and progression. This study aimed to identify biomarkers closely associated with disulfidptosis in anaplastic thyroid carcinoma (ATC). Utilizing ATC-related datasets (GSE65144, GSE9115, GSE27155, and GSE53072) in conjunction with disulfide bond-related genes (DRGs) identified in the literature, differentially expressed genes (DEGs) were screened from the GSE65144 and GSE9115 datasets. A total of 113 common DEGs were identified through cross-sectional analysis. Weighted gene co-expression network analysis (WGCNA) was employed to screen genes related to disulfidptosis and ATC, and five biomarkers-ATP1B3, TFF3, LGALS1, ADAM12, and COL1A2-were identified using machine learning algorithms. A nomogram model constructed based on these markers demonstrated high accuracy. In vitro validation revealed that ATP1B3 knockdown significantly inhibited tumor growth, indicating its potential anti-ATC activity. Furthermore, laser confocal microscopy, flow cytometry, and other experimental methods suggested a correlation between ATP1B3 and disulfidptosis. These findings highlight ATP1B3, TFF3, LGALS1, ADAM12, and COL1A2 as potential disulfidptosis-related biomarkers in ATC. This study provides a theoretical foundation for understanding the role of disulfidptosis in ATC pathogenesis and suggests that ATP1B3 may serve as a promising therapeutic target. - Source: PubMed
Publication date: 2026/04/22
Teng WeidongGuo YawenDing LinglingZhou AoniGuo YehaoHe JiantongZhang LirongYu HaolanTao ZekaiWang JiafengXu JiajieTan ZhuoJiang Liehao - Currently, there are no effective drug treatments for aging. Mendelian randomization (MR) has been widely applied to repurpose existing drugs and identify new therapeutic targets. Our aim is to identify aging-related therapeutic targets and evaluate their potential adverse effects, underlying mechanisms, and actionable drugs. - Source: PubMed
Publication date: 2026/03/29
Zhang YanfangWang MenglongLi HangJin TingPeng ShanshanDong YiDeng ChaoweiLi HangLi XinyiQin JuanjuanYe Xujun - To identify and functionally characterize the pig septin12 gene, including its expression pattern, subcellular localization, and interacting proteins, to explore its potential roles in male reproduction. - Source: PubMed
Publication date: 2026/04/02
Wang PeiWang XiaHuo HailongLi LuogangWen FeidiWang ShuyanZhang YongYunTurgong RenaguliHuo Jinlong - Transarterial chemoembolization (TACE) is the standard treatment for intermediate-stage hepatocellular carcinoma (HCC), but resistance to TACE is a major clinical challenge. This study aimed to identify genes associated with TACE refractoriness and their roles in HCC progression. - Source: PubMed
Publication date: 2025/11/19
Zhang CongHu QinMeng HuiWu QingqingZeng LuluZheng LiyunWeng QiaoyouQiu RongfangXu MinChen MinjiangChen FengZhao ZhongweiYang YangJi Jiansong - High levels of HBV DNA and HBsAg titres increase the risk of mother-to-child transmission. Development of adaptive immunity post HBV vaccination in neonates born to HBsAg-positive mothers may be determined by maternal HBsAg titres. We analysed pre- and post-HBV vaccination immune status in neonates. - Source: PubMed
Pahwa PrabhjyotiSingh RavinderChattopadhyay ParthaMehta PriyankaVyas Ashish KumarPatra ShardaTyagi ShakunPandey RajeshSarin Shiv KumarTrehanpati Nirupama